307 results on '"Tanese, Keiji"'
Search Results
2. Biomarkers and patient-related factors associated with clinical outcomes in dupilumab-treated atopic dermatitis
3. Visualization of intradermal blood vessel structures by dual-wavelength photoacoustic microscopy and characterization of three-dimensional construction of livedo-racemosa in cutaneous polyarteritis nodosa
4. Multifaceted analysis of cross-tissue transcriptomes reveals phenotype–endotype associations in atopic dermatitis
5. Role of androgen signaling in androgen receptor-positive extramammary Paget's disease: Establishment of organoids and their biological analysis as a novel therapeutic target
6. Cutaneous Inflammatory Pseudotumour of the Face; Does this Almost Forgotten Disease Concept Still Exist
7. Clinical and laboratory findings characterizing the need for systemic corticosteroids and nonsteroidal systemic therapies and the predicted outcomes in cutaneous polyarteritis nodosa: a single-centre retrospective analysis.
8. Impact of the changes in the completion lymph node dissection criteria and approval of adjuvant therapies on the real-world outcomes of Japanese stage III melanoma patients
9. Phase II clinical trial of docetaxel and trastuzumab for HER2-positive advanced extramammary Paget's disease (EMPD-HER2DOC).
10. Apremilast is a potentially useful treatment for severe palmoplantar pustulosis with extra‐palmoplantar symptoms
11. The role of macrophage migration inhibitory factor family and CD74 in the pathogenesis of melanoma.
12. Imatinib mesylate in combination with pembrolizumab in patients with advanced KIT-mutant melanoma following progression on standard therapy: A phase I/II trial and study protocol
13. Comprehensive Genomic Characterization of Staphylococcus aureus Isolated from Atopic Dermatitis Patients in Japan: Correlations with Disease Severity, Eruption Type, and Anatomical Site
14. Anti-PD-1 antibody therapy for epithelial skin malignancies: An investigator-initiated, open-label, single-arm, multicenter, phase II clinical trial (NMSC-PD1 Study)
15. Exploration of biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab: A study protocol
16. Barrier Factors of Adherence to Dupilumab Self-Injection for Severe Allergic Disease: A Non-Interventional Open-Label Study
17. S-1 in combination with docetaxel as salvage therapy for patients with metastatic extramammary Paget’s disease
18. Diagnosis and Management of Basal Cell Carcinoma
19. Supplementary Table S1 from Inflammatory Marker Testing Identifies CD74 Expression in Melanoma Tumor Cells, and Its Expression Associates with Favorable Survival for Stage III Melanoma
20. Supplemantary Figure S1 from Inflammatory Marker Testing Identifies CD74 Expression in Melanoma Tumor Cells, and Its Expression Associates with Favorable Survival for Stage III Melanoma
21. Supplementary Material S2 from Inflammatory Marker Testing Identifies CD74 Expression in Melanoma Tumor Cells, and Its Expression Associates with Favorable Survival for Stage III Melanoma
22. Barrier Factors of Adherence to Dupilumab Self-Injection for Severe Allergic Disease: A Non-Interventional Open-Label Study
23. Cutaneous inflammatory pseudotumour of the face; does this almost forgotten disease concept still exist?
24. Cell Surface CD74–MIF Interactions Drive Melanoma Survival in Response to Interferon-γ
25. Exploring biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab (B‐PAD study)
26. Cutaneous eyelid melanoma with lacrimal sac metastasis: the potential role of lacrimal fluid as a metastatic pathway
27. Atypical fibroxanthoma with prominent CD8‐positive lymphocytic infiltration and diffuse expression of epithelial membrane antigen
28. Atypisches Fibroxanthom mit auffälligem CD8‐positiven lymphozytären Infiltrat und diffuser Expression des epithelialen Membranantigens
29. Severe lichenoid eruption due to concomitant medications following nivolumab administration.
30. Assessment of the methods used to detect HER2-positive advanced extramammary Paget’s disease
31. A case of primary malignant melanoma of the lung responded to anti-PD-1 antibody therapy
32. Multifaceted analysis of cross-tissue, cross-sectional and longitudinal transcriptomes reveals phenotype–endotype associations in atopic dermatitis.
33. Leucine-rich repeat-containing G protein-coupled receptor 5 regulates epithelial cell phenotype and survival of hepatocellular carcinoma cells
34. Case of isolated epidermolytic acanthoma: Genetic and immunohistochemical analysis
35. Infiltration of mast cells in pachydermia of pachydermoperiostosis
36. Case of primary cutaneous methotrexate‐associated Hodgkinʼs lymphoma
37. Case of squamous cell carcinoma showing delayed metastasis and histologically exhibiting alterations of the surrounding immune cell populations along with the tumor invasion: Expression of monocyte chemotactic protein‐1 in deeply invaded tumor cells and interleukin‐6 in surrounding histiocytes
38. Identification of mutations in the prostaglandin transporter gene SLCO2A1 and its phenotype–genotype correlation in Japanese patients with pachydermoperiostosis
39. Management and outcomes of hydronephrosis in patients with metastatic extramammary Paget’s disease: A retrospective analysis
40. Marked decrease in serum squamous cell carcinoma antigen level after antitumor necrosis factor alpha therapy in six cases of severe psoriasis
41. Case of syringomatous carcinoma: Positive immunohistochemical staining of c-KIT and phosphorylated-extracellular signal-regulated kinase 1/2
42. Overexpression of adenylate cyclase-associated protein 2 is a novel prognostic marker in malignant melanoma
43. Case of primary cutaneous adenoid cystic carcinoma: Expression of c-KIT and activation of its downstream signaling molecules
44. Metastatic eccrine porocarcinoma successfully treated with carboplatin and epirubicin chemotherapy
45. Pathological characterization of pachydermia in pachydermoperiostosis
46. Efficacy of hydroxychloroquine for treating annular erythema associated with Sjögren’s syndrome
47. Eosinophilic annular erythema showing eosinophil cytolytic ETosis successfully treated with benralizumab
48. G-Protein-Coupled Receptor GPR49 is Up-regulated in Basal Cell Carcinoma and Promotes Cell Proliferation and Tumor Formation
49. Outcomes in patients with extramammary Paget disease with brain metastasis: A retrospective analysis
50. Toxic epidermal necrolysis in the absence of circulating T cells: A possible role for resident memory T cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.